Model Number 305 |
Device Problems
Gradient Increase (1270); Structural Problem (2506); Material Distortion (2977)
|
Patient Problems
Corneal Pannus (1447); Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758); Cusp Tear (2656)
|
Event Date 09/28/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
The product has been returned and analysis is in progress.Upon completion of analysis, a supplemental report will be submitted.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that 11 years post implant of this aortic bioprosthetic valve, echocardiogram showed stenosis, regurgitation, elevated gradients and a leaflet tear.The valve was explanted and replaced with a non-medtronic valve.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: upon receipt at medtronic¿s quality laboratory, visual inspection showed the valve was slightly distorted; oval shaped.The sewing ring appeared to have been cut and/or removed during explant exposing the stent.All leaflets were in the closed position however, due to calcification, the free margins and part of the leaflet lunula had deteriorated, creating a gap at the point of coaptation.All leaflets were stiff but slightly flexible except where visible calcification and pannus extended on the inflow and outflow.Tissue deterioration due to visible calcification was observed on all leaflets and on all commissures.There was no evidence of commissure dehiscence.Pannus on the inflow extended from the sewing ring to the base stitching encroaching 1 to 6mm onto the left and non-coronary cusps and into all inferior coaptive areas.Thick pannus was observed across the middle of the right cusp (inflow).The observed pannus contributed to the reduced inflow orifice area.Extrinsic calcification was noted on the existing cusps.An unknown amount of pannus appeared to have been removed during explant.Radiography revealed calcification in all leaflets and commissures.Reduced performance of the valve is attributed to host tissue overgrowth.This finding is generally considered a patient-related condition.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Added serial number.Added expiration date.Added unique identifier (udi).Added device manufacture date.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|